Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 91 of 1,261
  1. US 12102637

    Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

    Neurocrine Biosciences, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  2. US 12102642

    Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  3. US 12104163

    Adeno-associated virus vectors for treatment of Rett syndrome

    Sarepta Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  4. US 12102687

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  5. US 12104184

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  6. US 12104188

    Modified caspase-9 polypeptides and methods of use thereof

    Allogene Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  7. WO 2024194388

    PREPARATION DE LEVURE SACCHAROMYCES BOULARDII INACTIVEE

    BIOCODEX [FR] · Granted Sep 26, 2024 · Expires Sep 21, 2044

    granted
  8. US 12097290

    Membrane encapsulated nanoparticles and method of use

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  9. US 12097196

    Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  10. US 12098141

    Bicyclic indazole glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  11. US 12097213

    Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  12. US 12097199

    Administration of SUMO-activating enzyme inhibitor and anti-CD20 antibodies

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  13. US 12098138

    Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases

    The Board of Regents of the University of Texas System · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  14. US 12098385

    Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  15. US 12098118

    Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction

    Regents of the University of Minnesota · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  16. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  17. US 12097306

    Conformal coating of biological surfaces

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  18. US 12097223

    Mesenchymal stromal cells and uses related thereto

    Astellas Institute for Regenerative Medicine · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  19. US 12098215

    Fusion protein construct

    Northwestern University · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  20. US 12098144

    Piperazine indazole glucocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  21. US 12097263

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  22. US 12097262

    mTORC1 inhibitors

    The Regents of the University of California · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  23. US 12098116

    Crystalline prostacyclin (IP) receptor agonist and uses thereof

    United Therapeutics Corporation · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  24. US 12097261

    CDK2 degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.